Clinical studies have demonstrated that Semaglutide users can achieve weight loss ranging from 12% to 20% of their initial weight. At Balance Wellspace, our dedicated team conducted an eight-week program with a group of eight participants in Denver, resulting in a combined weight loss of 152 lbs., with minimal side effects. One participant successfully reached their target weight and completed the program, while seven others continue to progress toward their goals.

Semaglutide acts as a GLP-1 agonist, mimicking the natural hormone GLP-1. By slowing stomach emptying and signaling fullness to the brain, Semaglutide reduces food intake and suppresses appetite, facilitating weight loss.